HomePortfoliosFLT - SPYL/XMED/XDEW/CNDX/IUMO

FLT - SPYL/XMED/XDEW/CNDX/IUMO

Optimize
None Rebalancing
USD
Moderate Risk
2.6yr backtest

Performance Summary

Total Return+88.17%
Annualized Return+27.13%
Volatility+14.07%
Sharpe Ratio1.79
Max Drawdown+16.95%

Holdings

Asset Allocation

Asset Class

Equity 100.0%
Holdings Details
A diversified US & European equity ETF portfolio focused on S&P 500, Nasdaq 100, and momentum factor strategies for growth.
AssetTypeAllocationTER
SPYL.LSE
SPDR S&P 500 UCITS ETF (Acc)IE000XZSV718
ETF
30.0%0.03%
XMED.LSE
Xtrackers MSCI Europe UCITS ETF 1CLU0274209237
ETF
25.0%0.12%
XDEW.LSE
Xtrackers S&P 500 Equal Weight UCITS ETF 1CIE00BLNMYC90
ETF
20.0%0.15%
IUMO.LSE
iShares Edge MSCI USA Momentum Factor UCITS ETFIE00BD1F4N50
ETF
15.0%0.2%
CNDX.LSE
iShares Nasdaq 100 UCITS ETF (Acc)IE00B53SZB19
ETF
10.0%0.3%
Total100.0%0.13%

Performance

Portfolio Value Over Time
Starting with $10,000 investment → now worth $18,816.97
Histogram of Monthly Returns
The portfolio had a positive return during 26 of the 33 months (79%)
Monthly Returns Heatmap
Best month: +11.6% • Worst month: -7.5% • Best year: 2025 (+20.4%) • Worst year: 2026 (+14.3%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026+2.0%+0.8%-7.5%+11.6%+6.6%+1.1%------+14.3%
2025+4.5%-1.9%-4.2%+0.9%+6.8%+3.9%+1.4%+1.5%+2.8%+1.8%+0.2%+1.5%+20.4%
2024+1.4%+4.0%+3.8%-3.2%+3.0%+3.2%+0.7%+2.0%+2.3%-1.5%+3.7%-2.5%+17.9%
2023---------+0.0%+9.4%+6.0%+15.9%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +16.95% • The longest drawdown period lasted for 2 months and was between February 2025 and May 2025. It reached a trough of -17.0%.

Detailed Metrics

Returns
Total Return
+88.17%
Annualized Return
+27.13%
Avg Monthly Return
+2.00%
Risk
Volatility (Annual)
+14.07%
Max Drawdown
+16.95%
Positive Months
79%
Average Drawdown
-2.0%
Risk-Adjusted
Sharpe Ratio
1.79
Risk-free rate: 2.0%
Sortino Ratio
1.77
Downside risk adjusted
Return/Volatility
1.93
Calmar Ratio
1.60
Return/Max Drawdown
Ulcer Index
2.78
Drawdown depth & duration
Martin Ratio
0.09
Return/Ulcer Index
Backtest Configuration
Initial Investment
$10,000
Final Value
$18,816.97
Backtest Period
2023-10-31 to 2026-06-19
2.6 years
Rebalancing
none
Base Currency
USD
FLT - SPYL/XMED/XDEW/CNDX/IUMO | +27.1% CAGR | ETF Backtest